Cached score snapshot

US.LH · Labcorp

110分制 69/110;5D動能v2 29/50;排序分 98/160 · Incomplete inputs

Ranking score 98/160
Main score 69/110
5D momentum v2 29/50
Rank #3
Setup grade D 45.7

Score breakdown

謹慎買入

Medium twelvedata

Score and price trend

D 45.7 Money flow A · Technical A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 04-30 06-03 07-08 08-10 09-07 $241.32$294.05$346.77 Price Projection date
Historical projection
Model Median P25/P75 Win rate Down5 Actual / compare
Rolling DOE best · score 2.383 · anchors 120 -0.23% -2.15% / +1.78% 46.2% 6.8% Actual outcome pending · 0 / 3 bars observed
30D observation +1.99% -6.37% / +8.58% 56.4% 28% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 -0.34% -2.39% / +1.58% 43.8% 6.9% Actual outcome pending · 0 / 10 bars observed

Historical projection is based on archived similar setups. It is not a recommendation or guaranteed forecast.

2026-04-30 → 2026-09-07 · 90 archived points · 5 Improving turn signal · 5 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 98
Display grade 謹慎買入
Model version cursor_18_27_news_v2_160
Main score 69/110 (謹慎買入)
5D momentum v2 29/50 (中)
Score with momentum v2 98/160 (觀察)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Incomplete score

此 snapshot 已計出評分,但以下輸入仍不完整;缺失維度以 0 分處理,請留意 audit 明细。

  • VIX_MISSING: VIX market context is required for market environment scoring

Market inputs

Bar count 60
ma20 282.5975
ma50 269.4468
close 301.3
prevClose 296.77
avgVolume20 716314
volumeRatio 1.19
changePercent 1.53

Metrics snapshot

close 301.3
volume 853776
changePercent 1.53

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 69/110
Main rating 謹慎買入
5D momentum v2 29/50
Score with momentum v2 98/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.3/5 · 一般

Dimension score 3.3/5
Dimension grade 一般

Sub-items

pbPoints 0.4
pePoints 0.2
epsPoints 0.6
roePoints 0.4
debtPoints 0.4
marginPoints 0
turnoverUsdM 257.2427
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 15.6/20 · 良好

Dimension score 15.6/20
Dimension grade 良好

Sub-items

cmfPoints 2.4
mfiPoints 3.2
obvPoints 4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.LH
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 4.6/15 · 較差

Dimension score 4.6/15
Dimension grade 較差

Sub-items

vix

score 0

details

source twelvedata+fred
missing true
vixClose n/a

trend

score 0.8

details

qqq

ma20 710.49
ma50 717.6342
name QQQ
close 682.06
points 0.4

spy

ma20 746.6545
ma50 745.0022
name SPY
close 739.02
points 0.4
source twelvedata+fred
atrPct 2.7038
atrPoints 3
cciPoints 0.8
vixPoints 0
marketTrendPoints 0.8

催化劑 — 10/20 · 較差

Dimension score 10/20
Dimension grade 較差

Sub-items

catalyst

score 10

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 2
catalystPoints 10

風險管理 — 7.2/10 · 良好

Dimension score 7.2/10
Dimension grade 良好

Sub-items

position

score 1.6

details

atrPct 2.7038
turnoverUsdM 257.2427
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.8

stopLevels

symbol US.LH
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 285.0072

strength_details

ma_score 1.5
atr_score 2
rsi_score 3
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.7
stop_loss_percent 5.4
take_profit_price 329.3779
target_multiplier 2.2
technical_strength 2.35
take_profit_percent 9.3
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.7198
stopLossPercent 5.4075
diversificationPoints 2

技術信號 — 22.3/30 · 良好

Dimension score 22.3/30
Dimension grade 良好

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 1.4
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 1.4
vcp_reason 站上MA50;升放量(近10日3日);收盤突破20日高位;Ready=N;Confirm=Y

vcp_metrics

up_days 5
vol_ref 689423.3333
down_days 4
vcp_ready false
above_ma50 true
avg_vol_10 799320
avg_vol_20 725325
avg_vol_30 689423.3333
range_pct_10 0.121
range_pct_20 0.121
range_pct_30 0.1511
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok false
up_expand_days 3
breakout_20d_ok true
vol_ratio_10_30 1.1594
dist_to_20d_high -0.0091
down_shrink_days 0
breakout_level_20d 298.58
vcp_breakout_confirm true
contraction_ratio_10_30 0.801
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.7
rsiKdjPoints 3.2
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.8
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 1.2

情緒分析 — 6/10 · 一般

Dimension score 6/10
Dimension grade 一般

Sub-items

sentiment

score 6

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 4
sentimentScoreRaw 1.2

sentimentData

raw {"id":141013687,"url":"https://finnhub.io/api/news?id=799f54c6f74684aea37d6616d713755d15f5c7a914c842ec363dc06cc5365f86","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings (LH) is in focus after recent commentary highlighted rising analyst optimism ahead of its June 2026 quarter earnings, with expectations for higher revenue and year over year earnings growth. See our latest analysis for Labcorp Holdings. The Labcorp Holdings share price has gained 11.9% over the past month and 17.9% year to date. The 3 year total shareholder return of 43.4% points to sustained interest alongside the more recent pickup in momentum. If you are looking beyond...","category":"company","datetime":1784949554,"headline":"Labcorp Holdings (LH) Draws Fresh Earnings Optimism, Is It Still 4% Undervalued?"}, {"id":141006633,"url":"https://finnhub.io/api/news?id=8bc15cdae958b1e03a3bf47ad96f8a800793fbb0c9f62ff1e3c2727201fc0b67","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1784898903,"headline":"Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?"}, {"id":141005500,"url":"https://finnhub.io/api/news?id=cf321bf4499cb34d67bd3155505fe14aad25737f6e0ad655428bfb506f3d8909","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings recently drew attention as analysts revised their earnings estimates slightly higher ahead of its June 2026 quarter results, reflecting expectations for higher revenue and year-over-year earnings growth. This shift in analyst forecasts suggests growing confidence in Labcorp’s near-term profit outlook, adding a new layer to its existing growth story. We’ll now examine how this recent uptick in earnings expectations could influence Labcorp’s broader investment narrative and...","category":"company","datetime":1784895208,"headline":"Should Analyst Upgrades to Earnings Outlook Require Action From Labcorp (LH) Investors?"}, {"id":141005501,"url":"https://finnhub.io/api/news?id=e1eb576a72c7615322455ae0cd570713531a7773fa0827731f418500bdb15d0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.","category":"company","datetime":1784892240,"headline":"Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?"}, {"id":140995016,"url":"https://finnhub.io/api/news?id=f756aef7c16ca88263e9cec4c199547710d5673f667c497c10b233e0f3a16a84","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1784815238,"headline":"Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?"}, {"id":140973589,"url":"https://finnhub.io/api/news?id=d26bc0967a3ca10425daa181efc6cbf68be3ce0a2bce89bb5a9af85d196ccf08","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.","category":"company","datetime":1784650204,"headline":"Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?"}, {"id":140782807,"url":"https://finnhub.io/api/news?id=67d747b0e4de7ac62347615064d2cb439961b24f91a7a1a938f941d01938ecdb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"LH vs. CRL: Which Stock Is the Better Value Option?","category":"company","datetime":1782920405,"headline":"LH or CRL: Which Is the Better Value Stock Right Now?"}, {"id":140745849,"url":"https://finnhub.io/api/news?id=9f134601870442471946463b5cc9525da1a4984250f9aa0de6304425ca886362","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare Advantage patients and aligned with major U.S. screening guidelines. The test’s combination of RNA biomarker detection for both cancer and advanced adenomas, plus a simplified at-home collection process, positions it as a potentially important addition to Labcorp’s colorectal screening...","category":"company","datetime":1782562268,"headline":"Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test"}
raw_source {"id":141037184,"url":"https://finnhub.io/api/news?id=22c4f92f3c88f3a96febcbbeb9e4c85d408b1e74e67000b972ad008f6e93b1f6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Bank of America's trading, investment banking and digital expansion drive growth, but rising costs and market volatility pose key challenges.","category":"company","datetime":1785183300,"headline":"Top Stock Reports for Bank of America, Netflix & TotalEnergies"}, {"id":141032302,"url":"https://finnhub.io/api/news?id=d0f43c1bd24348255c879346e693ffebd977e061af8d4fb785a2c68cddcb3e01","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of Marker by Labcorp™ Genetic Health Panel, a new offering designed to help consumers better understand inherited risks associated with more than 100 medically actionable health conditions. Available through Labcorp OnDemand, the panel analyzes 163 genes associated with hereditary cancer, cardiovascular conditions and metabolic conditions and includes access to licensed genetic cou","category":"company","datetime":1785153600,"headline":"Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing"}, {"id":141013687,"url":"https://finnhub.io/api/news?id=799f54c6f74684aea37d6616d713755d15f5c7a914c842ec363dc06cc5365f86","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings (LH) is in focus after recent commentary highlighted rising analyst optimism ahead of its June 2026 quarter earnings, with expectations for higher revenue and year over year earnings growth. See our latest analysis for Labcorp Holdings. The Labcorp Holdings share price has gained 11.9% over the past month and 17.9% year to date. The 3 year total shareholder return of 43.4% points to sustained interest alongside the more recent pickup in momentum. If you are looking beyond...","category":"company","datetime":1784949554,"headline":"Labcorp Holdings (LH) Draws Fresh Earnings Optimism, Is It Still 4% Undervalued?"}, {"id":141006632,"url":"https://finnhub.io/api/news?id=905eab1e184b5839c349ef11a85fea84bad91ef2e2ad7e118471fa28526f3158","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"BrightSpring Health Services, Inc. (BTSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1784901613,"headline":"BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?"}, {"id":141006633,"url":"https://finnhub.io/api/news?id=8bc15cdae958b1e03a3bf47ad96f8a800793fbb0c9f62ff1e3c2727201fc0b67","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1784898903,"headline":"Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?"}, {"id":141005499,"url":"https://finnhub.io/api/news?id=adadddc876ba84463f58b1cf0662436d7a28ed432082d12c778cbd0425044113","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 9.7% over the past six months, topping the S&P 500 by 1.8 percentage points.","category":"company","datetime":1784898308,"headline":"1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds"}, {"id":141005500,"url":"https://finnhub.io/api/news?id=cf321bf4499cb34d67bd3155505fe14aad25737f6e0ad655428bfb506f3d8909","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings recently drew attention as analysts revised their earnings estimates slightly higher ahead of its June 2026 quarter results, reflecting expectations for higher revenue and year-over-year earnings growth. This shift in analyst forecasts suggests growing confidence in Labcorp’s near-term profit outlook, adding a new layer to its existing growth story. We’ll now examine how this recent uptick in earnings expectations could influence Labcorp’s broader investment narrative and...","category":"company","datetime":1784895208,"headline":"Should Analyst Upgrades to Earnings Outlook Require Action From Labcorp (LH) Investors?"}, {"id":141005501,"url":"https://finnhub.io/api/news?id=e1eb576a72c7615322455ae0cd570713531a7773fa0827731f418500bdb15d0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.","category":"company","datetime":1784892240,"headline":"Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?"}, {"id":140995016,"url":"https://finnhub.io/api/news?id=f756aef7c16ca88263e9cec4c199547710d5673f667c497c10b233e0f3a16a84","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1784815238,"headline":"Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?"}, {"id":140981940,"url":"https://finnhub.io/api/news?id=4ef76ce27eda81d626046a0e4578b307154512d58d22f0a60cb0d85499f4330a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.","category":"company","datetime":1784723820,"headline":"Labcorp Prepares to Report Q2 Earnings: What's in the Cards?"}, {"id":140973589,"url":"https://finnhub.io/api/news?id=d26bc0967a3ca10425daa181efc6cbf68be3ce0a2bce89bb5a9af85d196ccf08","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.","category":"company","datetime":1784650204,"headline":"Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?"}, {"id":140960859,"url":"https://finnhub.io/api/news?id=97af80ad8ab4420f78a1207f54a4d08df4680ba053061f1404d83440a6f0dda2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"EW heads into Q2 earnings results with estimates calling for double-digit revenue growth as TAVR, TMTT and Surgical heart businesses remain in focus.","category":"company","datetime":1784553780,"headline":"Edwards' Q2 Earnings on the Horizon: What's in the Cards?"}, {"id":140917339,"url":"https://finnhub.io/api/news?id=1f27600ea334c5b64cdbb9db553eb2b5fbc9ef3641296bb4fc92f47cd3e9094a","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442853868/image_1442853868.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"LH","summary":"Labcorp (LH) stock: rollup strategy, automation-driven cost cuts, and predictable 10% return potential with low risk. See here to know why it’s a buy.","category":"company","datetime":1784170936,"headline":"Labcorp Holdings: The Story Has Not Changed Materially"}, {"id":140909795,"url":"https://finnhub.io/api/news?id=1b47d596112422920f3e6d85275e61af22568009f53e93748458b83d713e1535","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1784121301,"headline":"CVS Health Corporation (CVS) Soars to 52-Week High, Time to Cash Out?"}, {"id":140886801,"url":"https://finnhub.io/api/news?id=7d420c816dbd0ca60c63c87b0db6a2badae8d89bed18798b5b200cd4dd2335b1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"CNBC's 20th annual state business rankings just upended conventional wisdom about which state economy leads the country, and the runner-up is pulling in more foreign investment than anyone else on the list while quietly carrying one of the biggest economic vulnerabilities in the nation.","category":"company","datetime":1783957673,"headline":"New Study Reveals Strongest State Economies, Only 1 State Was Better Than Texas"}, {"id":140891074,"url":"https://finnhub.io/api/news?id=76313e6bfc9d7a0f4adfbf977818ff53b1b4e667d0f731e94ae37e7e66c31a90","image":"","source":"Benzinga","related":"LH","summary":"B of A Securities analyst Michael Ryskin maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $300 to $320.","category":"company","datetime":1783950290,"headline":"B of A Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $320"}, {"id":140891075,"url":"https://finnhub.io/api/news?id=8e6e4fb168d8ccd5dce6fadbdbcfb7244398b77522704c310803250c4d4fae5b","image":"","source":"Benzinga","related":"LH","summary":"Baird analyst Eric Coldwell maintains Labcorp Holdings (NYSE:LH) with a Outperform and raises the price target from $335 to $338.","category":"company","datetime":1783950166,"headline":"Baird Maintains Outperform on Labcorp Holdings, Raises Price Target to $338"}, {"id":140855913,"url":"https://finnhub.io/api/news?id=49513bd95c37cd09ea1b913bb5e4351e83d6498e177eafca8261981d46a4cbc6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 11, 2026, to stockholders of record as of the close of business on August 28, 2026.","category":"company","datetime":1783631100,"headline":"Labcorp Declares Quarterly Dividend"}, {"id":140843493,"url":"https://finnhub.io/api/news?id=6965288a4937947801c099381791136a3fc20a3c219a24c1ece262f5eee177a5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.","category":"company","datetime":1783525800,"headline":"Will Strength in Biotechnology Unit Continue to Drive DHR's Growth?"}, {"id":140794209,"url":"https://finnhub.io/api/news?id=39df4a09978ea5917a26ef91114b734dd4aa7c9ce6a35a88ec41512f4ed4c2b5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings will report its second-quarter results by the end of this month, and analysts are anticipating a low-double-digit increase in earnings.","category":"company","datetime":1782995368,"headline":"Here's What to Expect From Labcorp Holdings’ Next Earnings Report"}, {"id":140782807,"url":"https://finnhub.io/api/news?id=67d747b0e4de7ac62347615064d2cb439961b24f91a7a1a938f941d01938ecdb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"LH vs. CRL: Which Stock Is the Better Value Option?","category":"company","datetime":1782920405,"headline":"LH or CRL: Which Is the Better Value Stock Right Now?"}, {"id":140775436,"url":"https://finnhub.io/api/news?id=51f896da7aeb3194feed45ecec490f36c9a1d345eef1bfd7f0c6268844eef81e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the \"News & Events\" section of the Labcorp Investor Relations website at https://ir.labcorp.com. A link","category":"company","datetime":1782850500,"headline":"Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026"}, {"id":140760977,"url":"https://finnhub.io/api/news?id=ea6a9eca47665b7f281eafec437e4516e7575fe15b2544e24417c5ef8ca6c82c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Omada Health, Inc. (OMDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.","category":"company","datetime":1782727020,"headline":"Omada Health, Inc. (OMDA) Stock Jumps 10.5%: Will It Continue to Soar?"}, {"id":140745849,"url":"https://finnhub.io/api/news?id=9f134601870442471946463b5cc9525da1a4984250f9aa0de6304425ca886362","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"LH","summary":"Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare Advantage patients and aligned with major U.S. screening guidelines. The test’s combination of RNA biomarker detection for both cancer and advanced adenomas, plus a simplified at-home collection process, positions it as a potentially important addition to Labcorp’s colorectal screening...","category":"company","datetime":1782562268,"headline":"Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 4
recomputed_at_score true
sentiment_score_raw 1.2
source_article_count 24
discarded_article_count 16
sentimentPoints 6

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.3 5/110 66% 3.3
資金流 15.6 20/110 78% 15.6
市場環境 4.6 15/110 30.67% 4.6
催化劑 10 20/110 50% 10
風險管理 7.2 10/110 72% 7.2
技術信號 22.3 30/110 74.33% 22.3
情緒分析 6 10/110 60% 6

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 29/50
ret_5d 0.0704
max_score 50
max_total 50
raw_total 29
vcp_bonus 0
vol_ratio 1.1771
ret_points 12
vol_points 2
range_ratio 0.8
volat_points 0
day_range_pct 0.0209
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 8
partial_history false
pullback_points 3
breakout_vol_bonus 0
first_breakout_20d true
return_window_days 5
first_breakout_bonus 2
breakout_quality_points 2

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.7038
turnoverUsdM 257.2427
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.8

stopLevels

symbol US.LH
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 285.0072

strength_details

ma_score 1.5
atr_score 2
rsi_score 3
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.7
stop_loss_percent 5.4
take_profit_price 329.3779
target_multiplier 2.2
technical_strength 2.35
take_profit_percent 9.3
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.7198
stopLossPercent 5.4075
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.3/5分
資金流分析總分: 15.6/20分
市場環境分析總分: 4.6/15分
催化劑分析: 10/20分
風險管理總分: 7.2/10分
技術信號分析總分: 22.3/30分
情緒分析: 6/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 8.1464
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.7
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 214.92
cmf
rule Cursor_18.24 CMF bands
level 輕微流入
score 6
value 0.1652
kdj
d 72.75
j 107.62
k 84.37
rule Cursor_18.24 K/D cross
score 4
signal 金叉
mfi
rule Cursor_18.24 MFI bands
level 入貨中
score 8
value 65.19
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value -432824
recentSlope 293677.6
previousSlope -141650
rsi
value 67.76
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 264.2667
position SAR喺價下
distancePct 12.29
previousTrend 上升
ma50
value 269.4468
macd
macd 6.5558
trend 強烈看漲
signal 4.9572
histogram 1.5986
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 283.0411
position 連續5日>VWAP
consecutiveAbove 23
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.19
score 6
avgVolume 716314
currentVolume 853776
derived
ma20 282.5975
ma50 269.4468
prevClose 296.77
avgVolume10 845068
avgVolume20 716314
changePercent 1.53
avgVolumeForScore 716314
ma_cross
ma20 282.5975
ma50 269.4468
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 281.106
prevMa50 268.5092
spreadPct 4.88
isVolumeBreakout false
bollinger
lower 268.7843
upper 296.4107
position 上半部
rsi_short
value 84.69
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.19

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.7037505046050616,
        "turnoverUsdM": 257.24270026224,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.LH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 285.0072,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.7,
      "stop_loss_percent": 5.4,
      "take_profit_price": 329.3779,
      "target_multiplier": 2.2,
      "technical_strength": 2.35,
      "take_profit_percent": 9.3
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.7198332435186094,
    "stopLossPercent": 5.407501009210123,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 98,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 69,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 29
  },
  "market": {
    "ma20": 282.5975,
    "ma50": 269.4468,
    "close": 301.3,
    "prevClose": 296.77,
    "avgVolume20": 716314,
    "volumeRatio": 1.19,
    "changePercent": 1.53
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 29,
    "details": {
      "ret_5d": 0.07041345493770579,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 29,
      "vcp_bonus": 0,
      "vol_ratio": 1.1770944059559507,
      "ret_points": 12,
      "vol_points": 2,
      "range_ratio": 0.7999616965672256,
      "volat_points": 0,
      "day_range_pct": 0.020942582839116597,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 2
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 98,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 66,
        "contribution": 3.3
      },
      {
        "raw": 15.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 78,
        "contribution": 15.6
      },
      {
        "raw": 4.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 30.67,
        "contribution": 4.6
      },
      {
        "raw": 10,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 22.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 74.33,
        "contribution": 22.3
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "謹慎買入",
    "result": 69,
    "details": [
      "基本面分析總分: 3.3/5分",
      "資金流分析總分: 15.6/20分",
      "市場環境分析總分: 4.6/15分",
      "催化劑分析: 10/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 22.3/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 10,
      "基本面": 3.3,
      "資金流": 15.6,
      "市場環境": 4.6,
      "情緒分析": 6,
      "技術信號": 22.3,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 10,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 2
            }
          },
          "catalystPoints": 10
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0.6,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 257.24270026224,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "良好",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 3.2,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.LH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 710.4899991500001,
                "ma50": 717.6342017599999,
                "name": "QQQ",
                "close": 682.059998,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.6545068500001,
                "ma50": 745.00220184,
                "name": "SPY",
                "close": 739.02002,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.7037505046050616,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 4,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141013687,
                "url": "https://finnhub.io/api/news?id=799f54c6f74684aea37d6616d713755d15f5c7a914c842ec363dc06cc5365f86",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (LH) is in focus after recent commentary highlighted rising analyst optimism ahead of its June 2026 quarter earnings, with expectations for higher revenue and year over year earnings growth. See our latest analysis for Labcorp Holdings. The Labcorp Holdings share price has gained 11.9% over the past month and 17.9% year to date. The 3 year total shareholder return of 43.4% points to sustained interest alongside the more recent pickup in momentum. If you are looking beyond...",
                "category": "company",
                "datetime": 1784949554,
                "headline": "Labcorp Holdings (LH) Draws Fresh Earnings Optimism, Is It Still 4% Undervalued?"
              },
              {
                "id": 141006633,
                "url": "https://finnhub.io/api/news?id=8bc15cdae958b1e03a3bf47ad96f8a800793fbb0c9f62ff1e3c2727201fc0b67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1784898903,
                "headline": "Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?"
              },
              {
                "id": 141005500,
                "url": "https://finnhub.io/api/news?id=cf321bf4499cb34d67bd3155505fe14aad25737f6e0ad655428bfb506f3d8909",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings recently drew attention as analysts revised their earnings estimates slightly higher ahead of its June 2026 quarter results, reflecting expectations for higher revenue and year-over-year earnings growth. This shift in analyst forecasts suggests growing confidence in Labcorp’s near-term profit outlook, adding a new layer to its existing growth story. We’ll now examine how this recent uptick in earnings expectations could influence Labcorp’s broader investment narrative and...",
                "category": "company",
                "datetime": 1784895208,
                "headline": "Should Analyst Upgrades to Earnings Outlook Require Action From Labcorp (LH) Investors?"
              },
              {
                "id": 141005501,
                "url": "https://finnhub.io/api/news?id=e1eb576a72c7615322455ae0cd570713531a7773fa0827731f418500bdb15d0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",
                "category": "company",
                "datetime": 1784892240,
                "headline": "Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?"
              },
              {
                "id": 140995016,
                "url": "https://finnhub.io/api/news?id=f756aef7c16ca88263e9cec4c199547710d5673f667c497c10b233e0f3a16a84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784815238,
                "headline": "Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?"
              },
              {
                "id": 140973589,
                "url": "https://finnhub.io/api/news?id=d26bc0967a3ca10425daa181efc6cbf68be3ce0a2bce89bb5a9af85d196ccf08",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1784650204,
                "headline": "Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 140782807,
                "url": "https://finnhub.io/api/news?id=67d747b0e4de7ac62347615064d2cb439961b24f91a7a1a938f941d01938ecdb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH vs. CRL: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1782920405,
                "headline": "LH or CRL: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 140745849,
                "url": "https://finnhub.io/api/news?id=9f134601870442471946463b5cc9525da1a4984250f9aa0de6304425ca886362",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare Advantage patients and aligned with major U.S. screening guidelines. The test’s combination of RNA biomarker detection for both cancer and advanced adenomas, plus a simplified at-home collection process, positions it as a potentially important addition to Labcorp’s colorectal screening...",
                "category": "company",
                "datetime": 1782562268,
                "headline": "Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test"
              }
            ],
            "raw_source": [
              {
                "id": 141037184,
                "url": "https://finnhub.io/api/news?id=22c4f92f3c88f3a96febcbbeb9e4c85d408b1e74e67000b972ad008f6e93b1f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Bank of America's trading, investment banking and digital expansion drive growth, but rising costs and market volatility pose key challenges.",
                "category": "company",
                "datetime": 1785183300,
                "headline": "Top Stock Reports for Bank of America, Netflix & TotalEnergies"
              },
              {
                "id": 141032302,
                "url": "https://finnhub.io/api/news?id=d0f43c1bd24348255c879346e693ffebd977e061af8d4fb785a2c68cddcb3e01",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of Marker by Labcorp™ Genetic Health Panel, a new offering designed to help consumers better understand inherited risks associated with more than 100 medically actionable health conditions. Available through Labcorp OnDemand, the panel analyzes 163 genes associated with hereditary cancer, cardiovascular conditions and metabolic conditions and includes access to licensed genetic cou",
                "category": "company",
                "datetime": 1785153600,
                "headline": "Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing"
              },
              {
                "id": 141013687,
                "url": "https://finnhub.io/api/news?id=799f54c6f74684aea37d6616d713755d15f5c7a914c842ec363dc06cc5365f86",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (LH) is in focus after recent commentary highlighted rising analyst optimism ahead of its June 2026 quarter earnings, with expectations for higher revenue and year over year earnings growth. See our latest analysis for Labcorp Holdings. The Labcorp Holdings share price has gained 11.9% over the past month and 17.9% year to date. The 3 year total shareholder return of 43.4% points to sustained interest alongside the more recent pickup in momentum. If you are looking beyond...",
                "category": "company",
                "datetime": 1784949554,
                "headline": "Labcorp Holdings (LH) Draws Fresh Earnings Optimism, Is It Still 4% Undervalued?"
              },
              {
                "id": 141006632,
                "url": "https://finnhub.io/api/news?id=905eab1e184b5839c349ef11a85fea84bad91ef2e2ad7e118471fa28526f3158",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "BrightSpring Health Services, Inc. (BTSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784901613,
                "headline": "BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy?"
              },
              {
                "id": 141006633,
                "url": "https://finnhub.io/api/news?id=8bc15cdae958b1e03a3bf47ad96f8a800793fbb0c9f62ff1e3c2727201fc0b67",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1784898903,
                "headline": "Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?"
              },
              {
                "id": 141005499,
                "url": "https://finnhub.io/api/news?id=adadddc876ba84463f58b1cf0662436d7a28ed432082d12c778cbd0425044113",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 9.7% over the past six months, topping the S&P 500 by 1.8 percentage points.",
                "category": "company",
                "datetime": 1784898308,
                "headline": "1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds"
              },
              {
                "id": 141005500,
                "url": "https://finnhub.io/api/news?id=cf321bf4499cb34d67bd3155505fe14aad25737f6e0ad655428bfb506f3d8909",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings recently drew attention as analysts revised their earnings estimates slightly higher ahead of its June 2026 quarter results, reflecting expectations for higher revenue and year-over-year earnings growth. This shift in analyst forecasts suggests growing confidence in Labcorp’s near-term profit outlook, adding a new layer to its existing growth story. We’ll now examine how this recent uptick in earnings expectations could influence Labcorp’s broader investment narrative and...",
                "category": "company",
                "datetime": 1784895208,
                "headline": "Should Analyst Upgrades to Earnings Outlook Require Action From Labcorp (LH) Investors?"
              },
              {
                "id": 141005501,
                "url": "https://finnhub.io/api/news?id=e1eb576a72c7615322455ae0cd570713531a7773fa0827731f418500bdb15d0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.",
                "category": "company",
                "datetime": 1784892240,
                "headline": "Strength Seen in Labcorp (LH): Can Its 3.4% Jump Turn into More Strength?"
              },
              {
                "id": 140995016,
                "url": "https://finnhub.io/api/news?id=f756aef7c16ca88263e9cec4c199547710d5673f667c497c10b233e0f3a16a84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1784815238,
                "headline": "Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?"
              },
              {
                "id": 140981940,
                "url": "https://finnhub.io/api/news?id=4ef76ce27eda81d626046a0e4578b307154512d58d22f0a60cb0d85499f4330a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.",
                "category": "company",
                "datetime": 1784723820,
                "headline": "Labcorp Prepares to Report Q2 Earnings: What's in the Cards?"
              },
              {
                "id": 140973589,
                "url": "https://finnhub.io/api/news?id=d26bc0967a3ca10425daa181efc6cbf68be3ce0a2bce89bb5a9af85d196ccf08",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1784650204,
                "headline": "Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?"
              },
              {
                "id": 140960859,
                "url": "https://finnhub.io/api/news?id=97af80ad8ab4420f78a1207f54a4d08df4680ba053061f1404d83440a6f0dda2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "EW heads into Q2 earnings results with estimates calling for double-digit revenue growth as TAVR, TMTT and Surgical heart businesses remain in focus.",
                "category": "company",
                "datetime": 1784553780,
                "headline": "Edwards' Q2 Earnings on the Horizon: What's in the Cards?"
              },
              {
                "id": 140917339,
                "url": "https://finnhub.io/api/news?id=1f27600ea334c5b64cdbb9db553eb2b5fbc9ef3641296bb4fc92f47cd3e9094a",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442853868/image_1442853868.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Labcorp (LH) stock: rollup strategy, automation-driven cost cuts, and predictable 10% return potential with low risk. See here to know why it’s a buy.",
                "category": "company",
                "datetime": 1784170936,
                "headline": "Labcorp Holdings: The Story Has Not Changed Materially"
              },
              {
                "id": 140909795,
                "url": "https://finnhub.io/api/news?id=1b47d596112422920f3e6d85275e61af22568009f53e93748458b83d713e1535",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
                "category": "company",
                "datetime": 1784121301,
                "headline": "CVS Health Corporation (CVS) Soars to 52-Week High, Time to Cash Out?"
              },
              {
                "id": 140886801,
                "url": "https://finnhub.io/api/news?id=7d420c816dbd0ca60c63c87b0db6a2badae8d89bed18798b5b200cd4dd2335b1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "CNBC's 20th annual state business rankings just upended conventional wisdom about which state economy leads the country, and the runner-up is pulling in more foreign investment than anyone else on the list while quietly carrying one of the biggest economic vulnerabilities in the nation.",
                "category": "company",
                "datetime": 1783957673,
                "headline": "New Study Reveals Strongest State Economies, Only 1 State Was Better Than Texas"
              },
              {
                "id": 140891074,
                "url": "https://finnhub.io/api/news?id=76313e6bfc9d7a0f4adfbf977818ff53b1b4e667d0f731e94ae37e7e66c31a90",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "B of A Securities  analyst Michael Ryskin   maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $300 to $320.",
                "category": "company",
                "datetime": 1783950290,
                "headline": "B of A Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $320"
              },
              {
                "id": 140891075,
                "url": "https://finnhub.io/api/news?id=8e6e4fb168d8ccd5dce6fadbdbcfb7244398b77522704c310803250c4d4fae5b",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Baird  analyst Eric Coldwell   maintains Labcorp Holdings (NYSE:LH) with a Outperform and raises the price target from $335 to $338.",
                "category": "company",
                "datetime": 1783950166,
                "headline": "Baird Maintains Outperform on Labcorp Holdings, Raises Price Target to $338"
              },
              {
                "id": 140855913,
                "url": "https://finnhub.io/api/news?id=49513bd95c37cd09ea1b913bb5e4351e83d6498e177eafca8261981d46a4cbc6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 11, 2026, to stockholders of record as of the close of business on August 28, 2026.",
                "category": "company",
                "datetime": 1783631100,
                "headline": "Labcorp Declares Quarterly Dividend"
              },
              {
                "id": 140843493,
                "url": "https://finnhub.io/api/news?id=6965288a4937947801c099381791136a3fc20a3c219a24c1ece262f5eee177a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Danaher's Biotechnology segment posts 7% core revenue growth as bioprocessing demand strengthened, even as weaker product demand created headwinds.",
                "category": "company",
                "datetime": 1783525800,
                "headline": "Will Strength in Biotechnology Unit Continue to Drive DHR's Growth?"
              },
              {
                "id": 140794209,
                "url": "https://finnhub.io/api/news?id=39df4a09978ea5917a26ef91114b734dd4aa7c9ce6a35a88ec41512f4ed4c2b5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings will report its second-quarter results by the end of this month, and analysts are anticipating a low-double-digit increase in earnings.",
                "category": "company",
                "datetime": 1782995368,
                "headline": "Here's What to Expect From Labcorp Holdings’ Next Earnings Report"
              },
              {
                "id": 140782807,
                "url": "https://finnhub.io/api/news?id=67d747b0e4de7ac62347615064d2cb439961b24f91a7a1a938f941d01938ecdb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH vs. CRL: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1782920405,
                "headline": "LH or CRL: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 140775436,
                "url": "https://finnhub.io/api/news?id=51f896da7aeb3194feed45ecec490f36c9a1d345eef1bfd7f0c6268844eef81e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the \"News & Events\" section of the Labcorp Investor Relations website at https://ir.labcorp.com. A link",
                "category": "company",
                "datetime": 1782850500,
                "headline": "Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026"
              },
              {
                "id": 140760977,
                "url": "https://finnhub.io/api/news?id=ea6a9eca47665b7f281eafec437e4516e7575fe15b2544e24417c5ef8ca6c82c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Omada Health, Inc. (OMDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.",
                "category": "company",
                "datetime": 1782727020,
                "headline": "Omada Health, Inc. (OMDA) Stock Jumps 10.5%: Will It Continue to Soar?"
              },
              {
                "id": 140745849,
                "url": "https://finnhub.io/api/news?id=9f134601870442471946463b5cc9525da1a4984250f9aa0de6304425ca886362",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home colorectal cancer screening test, now covered for eligible Medicare and Medicare Advantage patients and aligned with major U.S. screening guidelines. The test’s combination of RNA biomarker detection for both cancer and advanced adenomas, plus a simplified at-home collection process, positions it as a potentially important addition to Labcorp’s colorectal screening...",
                "category": "company",
                "datetime": 1782562268,
                "headline": "Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 4,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 24,
            "discarded_article_count": 16
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 22.3,
        "grade": "良好",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 1.4,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.4,
            "vcp_reason": "站上MA50;升放量(近10日3日);收盤突破20日高位;Ready=N;Confirm=Y",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 689423.3333333334,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 799320,
              "avg_vol_20": 725325,
              "avg_vol_30": 689423.3333333334,
              "range_pct_10": 0.12104215469771516,
              "range_pct_20": 0.12104215469771516,
              "range_pct_30": 0.1511118105247863,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 1.1594037528949315,
              "dist_to_20d_high": -0.009109786627027385,
              "down_shrink_days": 0,
              "breakout_level_20d": 298.57999,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.8010105515734064
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 3.2,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.7037505046050616,
              "turnoverUsdM": 257.24270026224,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.LH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 285.0072,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.7,
            "stop_loss_percent": 5.4,
            "take_profit_price": 329.3779,
            "target_multiplier": 2.2,
            "technical_strength": 2.35,
            "take_profit_percent": 9.3
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.7198332435186094,
          "stopLossPercent": 5.407501009210123,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.LH",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 8.1464,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.7
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 214.92
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1652
    },
    "kdj": {
      "d": 72.75,
      "j": 107.62,
      "k": 84.37,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 65.19
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -432824,
      "recentSlope": 293677.6,
      "previousSlope": -141650
    },
    "rsi": 67.76,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 264.2667,
      "position": "SAR喺價下",
      "distancePct": 12.29,
      "previousTrend": "上升"
    },
    "ma50": 269.4468,
    "macd": {
      "macd": 6.555792872774077,
      "trend": "強烈看漲",
      "signal": 4.957176597347194,
      "histogram": 1.598616275426883
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 283.0411,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 23
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.19,
      "score": 6,
      "avgVolume": 716314,
      "currentVolume": 853776
    },
    "derived": {
      "ma20": 282.5975,
      "ma50": 269.4468,
      "prevClose": 296.77,
      "avgVolume10": 845068,
      "avgVolume20": 716314,
      "changePercent": 1.53,
      "avgVolumeForScore": 716314
    },
    "ma_cross": {
      "ma20": 282.5975,
      "ma50": 269.4468,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 281.106,
      "prevMa50": 268.5092,
      "spreadPct": 4.88,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 268.7843,
      "upper": 296.4107,
      "position": "上半部"
    },
    "rsi_short": 84.69,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.19
    }
  }
}

Raw metrics JSON

{
  "close": 301.3,
  "volume": 853776,
  "changePercent": 1.53
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.